$3.51 -0.03 (-0.85%)
11/20/2009 4:00 PM

Arena Pharmaceuticals, Inc. (ARNA)

CAPS Rating: 3 out of 5

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.

Featured Broker Partners